Brooklyn ImmunoTherapeutics Inc. (BTX) Fundamentals

Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells.
SHARE INFORMATION
Market Cap$ 28,326,271
Shares Outstanding57,468,597
Float51,566,293
Percent Float89.73%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.61
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions151
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months1,143,344
Institutional Holdings Percent36.9%
Institutional Sold Previous 3 Months2,822,804
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months691,123
Insider Holdings Percent12.5
Insider Sold Previous 3 Months35,986
Insider Shares Owned7,207,058
TRADING INFO
52 Week High$ 13.63
52 Week Low$ 0.45
52 Week High Change$ -95.84
21 Day Moving Average$ 0.5424
21 Day Extended Moving Average$ 0.535165
50 Day Moving Average$ 0.5723
50 Day Extended Moving Average$ 0.659395
200 Day Moving Average$ 2.7982
200 Day Extended Moving Average$ 2.9967
10 Day Average Volume439,106
20 Day Average Volume393,106
30 Day Average Volume444,033
50 Day Average Volume601,344
Alpha0.107698
Beta4.5553
Standard Deviation1.630043
R20.019537
7 Day Price Change$ -0.0053
7 Day Percent Change-1.06%
21 Day Price Change$ -0.1106
21 Day Percent Change-18.33%
30 Day Price Change$ -0.2202
30 Day Percent Change-30.88%
Month to Date Price Change$ 0.0055
Month to Date Percent Change1.13%
Quarter to Date Price Change$ -0.0247
Quarter to Date Percent Change-4.77%
180 Day Price Change$ -1.99
180 Day Percent Change-80.13%
200 Day Price Change$ -2.18
200 Day Percent Change-81.54%
Year to Date Price Change$ -3.68
Year to Date Percent Change-88.18%

Brooklyn ImmunoTherapeutics Inc. (BTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.20
Total Debt To Equity0.10
Int Coverage-1,854.00
Current Ratio6.80
Leverage Ratio1.60
Quick Ratio6.60
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-0.20
Enterprise Value$ 7,390,758
Price to Sales0.00
Price to Free Cash-0.70
PE High Last 5 Years-3.20
Price To Book1.70
Price To Cash Flow7.20
PE Low Last 5 Years-16.10
Price to Tangible Book3.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-403.66
Return on Equity-1,756.29
Return on Capital-1,339.78

Brooklyn ImmunoTherapeutics Inc. (BTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEOMatthew Angel
Emplyoees10
Last AuditUE
CIK0000748592
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address10355 Science Center Drive
Suite 150
San Diego, CA 92121
Websitehttps://www.brooklynitx.com
Facsimile-
Telephone+1 212 582-1199
Email-


Your Recent History
AMEX
BTX
Brooklyn I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.